Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Recruiting · NCT05178498 · Observational (researchers observe without assigning treatment) · Lead sponsor: Ohio State University Comprehensive Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
Follow-UpPhysical ExaminationQuestionnaire Administration
What this trial is about
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \>= 18 years
- Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer \[BC\], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ \[LCIS\], or prior chest wall radiation)
- Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)
- Able to read and understand English
- Able to provide informed consent
- Must consent to continued follow-up of medical records during the study period
Exclusion criteria
- Prisoners
- Not able to speak and understand English
- Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC
Where it is running
1 location listed across 1 US state.
- Ohio State University Comprehensive Cancer Center - Columbus, Ohio, United States